# Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging

> **NCT07474779** · NA · NOT_YET_RECRUITING · sponsor: **University of Pavia** · enrollment: 160 (estimated)

## Conditions studied

- Parkinson's Disease (PD)
- GBA1 Parkinson Disease
- REM Sleep Behavior Disorder (iRBD)

## Interventions

- **DIAGNOSTIC_TEST:** brain imaging
- **PROCEDURE:** blood draw
- **PROCEDURE:** Skin biopsy

## Key facts

- **NCT ID:** NCT07474779
- **Lead sponsor:** University of Pavia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-11
- **Primary completion:** 2028-12
- **Final completion:** 2029-02
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07474779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07474779, "Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07474779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*